Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

EMEA (Europe, Middle East and Africa) Artificial Pancreas Systems Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Purchase Options

 
In this report, the EMEA Artificial Pancreas Systems market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Artificial Pancreas Systems for these regions, from 2018 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Artificial Pancreas Systems market competition by top manufacturers/players, with Artificial Pancreas Systems sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Medtronic Plc.
Johnson and Johnson Services Inc.
Dexcom Inc.
Insulet Corporation
Tandem Diabetes Care Inc.
Cellnovo
...

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Portable
Desktop
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Artificial Pancreas Systems for each application, including
Diabetes Type 1
Diabetes Type 2

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Artificial Pancreas Systems Market Report 2019
1 Artificial Pancreas Systems Overview
1.1 Product Overview and Scope of Artificial Pancreas Systems
1.2 Classification of Artificial Pancreas Systems
1.2.1 EMEA Artificial Pancreas Systems Market Size (Sales) Comparison by Type (2014-2024)
1.2.2 EMEA Artificial Pancreas Systems Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Portable
1.2.4 Desktop
1.2.5 Other
1.3 EMEA Artificial Pancreas Systems Market by Application/End Users
1.3.1 EMEA Artificial Pancreas Systems Sales (Volume) and Market Share Comparison by Application (2014-2024
1.3.2 Diabetes Type 1
1.3.3 Diabetes Type 2
1.4 EMEA Artificial Pancreas Systems Market by Region
1.4.1 EMEA Artificial Pancreas Systems Market Size (Value) Comparison by Region (2014-2024)
1.4.2 Europe Status and Prospect (2014-2024)
1.4.3 Middle East Status and Prospect (2014-2024)
1.4.4 Africa Status and Prospect (2014-2024)
1.5 EMEA Market Size (Value and Volume) of Artificial Pancreas Systems (2014-2024)
1.5.1 EMEA Artificial Pancreas Systems Sales and Growth Rate (2014-2024)
1.5.2 EMEA Artificial Pancreas Systems Revenue and Growth Rate (2014-2024)

2 EMEA Artificial Pancreas Systems Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Artificial Pancreas Systems Market Competition by Players/Manufacturers
2.1.1 EMEA Artificial Pancreas Systems Sales Volume and Market Share of Major Players (2014-2019)
2.1.2 EMEA Artificial Pancreas Systems Revenue and Share by Players (2014-2019)
2.1.3 EMEA Artificial Pancreas Systems Sale Price by Players (2014-2019)
2.2 EMEA Artificial Pancreas Systems (Volume and Value) by Type/Product Category
2.2.1 EMEA Artificial Pancreas Systems Sales and Market Share by Type (2014-2019)
2.2.2 EMEA Artificial Pancreas Systems Revenue and Market Share by Type (2014-2019)
2.2.3 EMEA Artificial Pancreas Systems Sale Price by Type (2014-2019)
2.3 EMEA Artificial Pancreas Systems (Volume) by Application
2.4 EMEA Artificial Pancreas Systems (Volume and Value) by Region
2.4.1 EMEA Artificial Pancreas Systems Sales and Market Share by Region (2014-2019)
2.4.2 EMEA Artificial Pancreas Systems Revenue and Market Share by Region (2014-2019)
2.4.3 EMEA Artificial Pancreas Systems Sales Price by Region (2014-2019)

3 Europe Artificial Pancreas Systems (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Artificial Pancreas Systems Sales and Value (2014-2019)
3.1.1 Europe Artificial Pancreas Systems Sales Volume and Growth Rate (2014-2019)
3.1.2 Europe Artificial Pancreas Systems Revenue and Growth Rate (2014-2019)
3.2 Europe Artificial Pancreas Systems Sales and Market Share by Type
3.3 Europe Artificial Pancreas Systems Sales and Market Share by Application
3.4 Europe Artificial Pancreas Systems Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Artificial Pancreas Systems Sales Volume by Countries (2014-2019)
3.4.2 Europe Artificial Pancreas Systems Revenue by Countries (2014-2019)
3.4.3 Germany Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
3.4.4 France Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
3.4.5 UK Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
3.4.6 Russia Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
3.4.7 Italy Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
3.4.8 Benelux Artificial Pancreas Systems Sales and Growth Rate (2014-2019)

4 Middle East Artificial Pancreas Systems (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Artificial Pancreas Systems Sales and Value (2014-2019)
4.1.1 Middle East Artificial Pancreas Systems Sales Volume and Growth Rate (2014-2019)
4.1.2 Middle East Artificial Pancreas Systems Revenue and Growth Rate (2014-2019)
4.2 Middle East Artificial Pancreas Systems Sales and Market Share by Type
4.3 Middle East Artificial Pancreas Systems Sales and Market Share by Application
4.4 Middle East Artificial Pancreas Systems Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Artificial Pancreas Systems Sales Volume by Countries (2014-2019)
4.4.2 Middle East Artificial Pancreas Systems Revenue by Countries (2014-2019)
4.4.3 Saudi Arabia Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
4.4.4 Israel Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
4.4.5 UAE Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
4.4.6 Iran Artificial Pancreas Systems Sales and Growth Rate (2014-2019)

5 Africa Artificial Pancreas Systems (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Artificial Pancreas Systems Sales and Value (2014-2019)
5.1.1 Africa Artificial Pancreas Systems Sales Volume and Growth Rate (2014-2019)
5.1.2 Africa Artificial Pancreas Systems Revenue and Growth Rate (2014-2019)
5.2 Africa Artificial Pancreas Systems Sales and Market Share by Type
5.3 Africa Artificial Pancreas Systems Sales and Market Share by Application
5.4 Africa Artificial Pancreas Systems Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Artificial Pancreas Systems Sales Volume by Countries (2014-2019)
5.4.2 Africa Artificial Pancreas Systems Revenue by Countries (2014-2019)
5.4.3 South Africa Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
5.4.4 Nigeria Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
5.4.5 Egypt Artificial Pancreas Systems Sales and Growth Rate (2014-2019)
5.4.6 Algeria Artificial Pancreas Systems Sales and Growth Rate (2014-2019)

6 EMEA Artificial Pancreas Systems Manufacturers/Players Profiles and Sales Data
6.1 Medtronic Plc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Artificial Pancreas Systems Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Medtronic Plc. Artificial Pancreas Systems Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Johnson and Johnson Services Inc.
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Artificial Pancreas Systems Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Johnson and Johnson Services Inc. Artificial Pancreas Systems Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Dexcom Inc.
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Artificial Pancreas Systems Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Dexcom Inc. Artificial Pancreas Systems Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Insulet Corporation
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Artificial Pancreas Systems Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Insulet Corporation Artificial Pancreas Systems Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 Tandem Diabetes Care Inc.
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Artificial Pancreas Systems Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Tandem Diabetes Care Inc. Artificial Pancreas Systems Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 Cellnovo
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Artificial Pancreas Systems Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Cellnovo Artificial Pancreas Systems Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
...

7 Artificial Pancreas Systems Manufacturing Cost Analysis
7.1 Artificial Pancreas Systems Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Artificial Pancreas Systems

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Artificial Pancreas Systems Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Artificial Pancreas Systems Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Artificial Pancreas Systems Market Forecast (2019-2024)
11.1 EMEA Artificial Pancreas Systems Sales, Revenue and Price Forecast (2019-2024)
11.1.1 EMEA Artificial Pancreas Systems Sales and Growth Rate Forecast (2019-2024)
11.1.2 EMEA Artificial Pancreas Systems Revenue and Growth Rate Forecast (2019-2024)
11.1.3 EMEA Artificial Pancreas Systems Price and Trend Forecast (2019-2024)
11.2 EMEA Artificial Pancreas Systems Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.3 Europe Artificial Pancreas Systems Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.4 Middle Eastt Artificial Pancreas Systems Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.5 Africa Artificial Pancreas Systems Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.6 EMEA Artificial Pancreas Systems Sales Forecast by Type (2019-2024)
11.7 EMEA Artificial Pancreas Systems Sales Forecast by Application (2019-2024)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us